Pediatrix Medical Group I...

NYSE: MD · Real-Time Price · USD
16.05
0.51 (3.28%)
At close: Aug 15, 2025, 3:13 PM

Pediatrix Medical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
109.92M -82.37M -99.07M -253.84M -251.89M -70.58M -60.41M 87.88M 95.3M 97.72M 62.57M 78.85M 81.89M 81.72M 108.01M 72.22M 32.45M 11.88M
Depreciation & Amortization
24.48M 27.95M 32.93M 35.12M 37.37M 37.53M 36.17M 36.24M 35.99M 35.82M 35.64M 34.36M 33.55M 32.88M 32.15M 31.98M 15.79M 17.8M
Stock-Based Compensation
14.4M 12.44M 11.87M 12.15M 11.21M 12.38M 12.32M 12.54M 13.49M 14.7M 16.13M 16.91M 18.29M 19.69M 18.97M 17.87M 34.67M 34.72M
Other Working Capital
78.66M 91.16M 107.36M 51.9M 58.35M 26.98M 147.04M 116.32M 143.29M 287.15M 36.95M 100.81M 112.31M 31.22M 491.08M 455.59M 426.87M 353.78M
Other Non-Cash Items
-4.69M 139.12M 139.94M 310.5M 302.88M 156.83M 157.63M -6.26M -9.99M -6.15M 43.55M 13.51M 13.99M -9.99M -27.8M -88.27M 38.22M 89.85M
Deferred Income Tax
39.4M 1.58M -2.13M -23.23M -30.16M 1.92M 3.24M -3.48M -12.5M -23.15M -22.77M -9.75M -16.1M -12.83M -31.24M -24.11M -36.55M -13.31M
Change in Working Capital
69.93M 76.47M 86.51M 25.58M 16.09M -22.46M -11.63M 39.84M 47.87M 44.58M 31.83M -21.39M -41.36M -50.03M -23.36M 10.95M 44.89M 127.91M
Operating Cash Flow
244.55M 214.34M 206.57M 142.81M 130.91M 113.02M 137.32M 166.76M 170.15M 163.51M 166.94M 112.49M 90.26M 61.44M 76.74M 20.64M 129.47M 268.86M
Capital Expenditures
-17.56M -20.01M -22.02M -27.63M -30.49M -31.66M -33.33M -33.34M -31.14M -29.56M -29.71M -23.82M -27.42M -30.34M -32.25M -36.06M -27.03M -27.16M
Cash Acquisitions
n/a n/a -8.17M -13.17M -13.17M -10.9M -4.4M 600K 600K -4.17M -28.17M -38.55M -50.89M -24.91M -5.2M 4.1M 14.89M -12.86M
Purchase of Investments
-46.16M -55.41M -64.55M -59.82M -54.05M -39.24M -31.89M -28.89M -22.12M -25.62M -17.35M -18.56M -39.68M -31.19M -35.05M -57.19M -37.87M -45.94M
Sales Maturities Of Investments
39.63M 45.64M 52.49M 51.67M 41.34M 30.2M 22.91M 17.56M 15.66M 16.04M 16.89M 16.89M 19.79M 16.77M 16.5M 18.06M 26.04M 31M
Other Investing Acitivies
3.2M -2.78M -1.84M -5.62M -7.86M -4.2M -4.14M -5.61M -4.76M -1.41M 1.38M 2.74M -16.55M 7.18M 9.43M 880.71M 889.68M 880.32M
Investing Cash Flow
-20.89M -26.63M -35.41M -45.89M -55.56M -53.06M -48.18M -46.99M -39.08M -42.03M -56.95M -61.3M -96.42M -68.98M -53.07M 803.12M 840.89M 825.37M
Debt Repayment
-17.97M -96.6M -15.39M -15.06M -56.1M -49.1M -19.12M -110.34M -128.06M -50.37M -413.1M -319.24M -257.39M -258.69M -762.66M -1.29B -1.29B -1.66B
Common Stock Repurchased
-2.58M -2.38M -1.7M -1.06M -1.03M -1.03M -919K -2.39M -23.73M -88.12M -88.51M -87.04M -68.04M -3.89M -4.72M -4.72M -7.7M -7.95M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-1.25M -1.18M -1.03M -2.09M -8.9M -12.62M -10.59M 425K 8.61M 13.69M 11.7M 3.43M 2.07M 682K 407K 527.31M 527.56M 527.56M
Financial Cash Flow
-18.33M -96.72M -14.48M -14.27M -61.8M -58.08M -25.71M -107.26M -139.31M -122.53M -487.55M -400.44M -317.91M -254.91M -760.12M -760.36M -764.36M -1.13B
Net Cash Flow
205.33M 90.98M 156.68M 82.65M 13.55M 1.87M 63.43M 12.51M -8.24M -1.05M -377.57M -349.25M -324.07M -262.45M -736.45M 63.4M 206.01M -42.52M
Free Cash Flow
235.87M 203.21M 193.43M 124.07M 100.42M 81.36M 104M 133.42M 139.02M 133.94M 137.23M 88.67M 62.85M 31.1M 44.49M -15.43M 102.44M 241.7M